Search Results

Invivyd, Inc. announced that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code covering product reimbursement for PEMGARDA.

Helius Medical Technologies, Inc. announced that the Centers for Medicare & Medicaid Services has assigned Healthcare Common Procedure Coding System Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece.

Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc., announced the editorial panel of the American Medical Association established a new Category I Current Procedural Terminology code for the use of optical genome mapping in cytogenomic genome-wide analysis to detect structural and copy number variations related to hematological malignancies.

SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.

NeuroOne Medical Technologies Corporation announced that the Centers for Medicare and Medicaid Services has approved and granted a new ICD-10-PCS code for the OneRF™ Ablation procedure.

Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable, Human Acellular Vessels at commercial scale, announced the issuance of four new ICD-10-PCS codes by the U.S. Centers for Medicare & Medicaid Services ICD-10 Coordination and Maintenance Committee.

Celularity Inc. announced that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code for Biovance® 3L, a tri-layer allograft derived from placental tissue intended for use as a biological membrane covering barrier or wrap that acts as a scaffold for restoration of functional tissue in partial- and full-thickness, acute and chronic wounds.

Axena Health, Inc., a medical device company focused on female pelvic health, welcomes the Centers for Medicare & Medicaid Services’ new Healthcare Common Procedure Coding System Level II code for the Leva® Pelvic Health System.

As the field of genomics continues to evolve, long non-coding RNAs (lncRNAs) have emerged as a fascinating frontier, offering unprecedented insights into the complex regulatory mechanisms underlying biological processes and disease states